COVID-19-associated invasive pulmonary aspergillosis: high incidence or difficult diagnosis?

Rouzé, Anahita; Lemaitre, Elise; Nseir, Saad

Rouzé, Anahita; Lemaitre, Elise; Nseir, Saad.

Rouzé A; Médecine Intensive-Réanimation, CHU de Lille, F-59000, Lille, France.
Lemaitre E; INSERM U1285, CNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, Université de Lille, F-59000, Lille, France.
Nseir S; Médecine Intensive-Réanimation, CHU de Lille, F-59000, Lille, France.

Intensive Care Med ; 47(11): 1337-1338, 2021 11.

Article in English | MEDLINE | ID: covidwho-1338201

Subject(s)

COVID-19; Invasive Pulmonary Aspergillosis; Humans; Incidence; Intensive Care Units; Invasive Pulmonary Aspergillosis/diagnosis; Invasive Pulmonary Aspergillosis/drug therapy; Invasive Pulmonary Aspergillosis/epidemiology; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Invasive Pulmonary Aspergillosis / COVID-19 Type of study: Diagnostic study / Observational study Limits: Humans Language: English Journal: Intensive Care Med Year: 2021 Document Type: Article Affiliation country: S00134-021-06499-8

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google